Scientific Sessions 2025  /  Innovations in Valvular Heart Disease: Talks from Basic Science to Clinical Trials to Breakthrough Innovations in Surgical and Transcatheter Therapies  /  Artificial Intelligence in Diagnosing Valvular Heart Disease--the Future is Now
Logo

American Heart Association

  35
  0

Final ID:

Artificial Intelligence in Diagnosing Valvular Heart Disease--the Future is Now

  • Holste, Gregory  ( Yale School of Medicine , New Haven , Connecticut , United States )
  • Namasivayam, Mayooran  ( St Vincent's Hospital Sydney , Darlinghurst , New South Wales , Australia )
  • Topol, Eric  ( SCRIPPS HEALTH , La Jolla , California , United States )
    • Author Disclosures:
    Gregory Holste: DO NOT have relevant financial relationships | Mayooran Namasivayam: No Answer | Eric Topol: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovations in Valvular Heart Disease: Talks from Basic Science to Clinical Trials to Breakthrough Innovations in Surgical and Transcatheter Therapies

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Innovations in AS Diagnosis by Electronic Provider Notification to Facilitate the Recognition and Management of Valvular Heart Disease

Tanguturi Varsha, Elmariah Sammy, Abou-karam Roukoz, Cheng Fangzhou

Translating Basic Science Innovations to Bedside Valvular Treatment

Cohn William, Bolling Steven, Del Nido Pedro

More abstracts from these authors:
Artificial Intelligence: towards the prediction, detection, and prevention of atrial fibrillation and stroke

Noseworthy Peter, Topol Eric

PanEcho: Complete AI-enabled echocardiography interpretation with multi-task deep learning

Holste Gregory, Oikonomou Evangelos, Wang Zhangyang, Khera Rohan

You have to be authorized to contact abstract author. Please, Login
Not Available